Your browser doesn't support javascript.
loading
Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection.
Pokorney, Sean D; Zepel, Lindsay; Greiner, Melissa A; Fowler, Vance G; Black-Maier, Eric; Lewis, Robert K; Hegland, Donald D; Granger, Christopher B; Epstein, Laurence M; Carrillo, Roger G; Wilkoff, Bruce L; Hardy, Chantelle; Piccini, Jonathan P.
Afiliación
  • Pokorney SD; Duke University Medical Center, Durham, North Carolina.
  • Zepel L; Duke Clinical Research Institute, Durham, North Carolina.
  • Greiner MA; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
  • Fowler VG; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
  • Black-Maier E; Duke University Medical Center, Durham, North Carolina.
  • Lewis RK; Duke Clinical Research Institute, Durham, North Carolina.
  • Hegland DD; Duke University Medical Center, Durham, North Carolina.
  • Granger CB; Duke University Medical Center, Durham, North Carolina.
  • Epstein LM; Duke University Medical Center, Durham, North Carolina.
  • Carrillo RG; Duke University Medical Center, Durham, North Carolina.
  • Wilkoff BL; Duke Clinical Research Institute, Durham, North Carolina.
  • Hardy C; Northwell Health, Manhasset, New York.
  • Piccini JP; University of Miami Palmetto General Hospital, Hialeah, Florida.
JAMA Cardiol ; 8(12): 1165-1173, 2023 12 01.
Article en En | MEDLINE | ID: mdl-37851461
ABSTRACT
Importance Complete hardware removal is a class I recommendation for cardiovascular implantable electronic device (CIED) infection, but practice patterns and outcomes remain unknown.

Objective:

To quantify the number of Medicare patients with CIED infections who underwent implantation from 2006 to 2019 and lead extraction from 2007 to 2019 to analyze the outcomes in these patients in a nationwide clinical practice cohort. Design, Setting, and

Participants:

This cohort study included fee-for-service Medicare Part D beneficiaries from January 1, 2006, to December 31, 2019, who had a de novo CIED implantation and a CIED infection more than 1 year after implantation. Data were analyzed from January 1, 2005, to December 31, 2019. Exposure A CIED infection, defined as (1) endocarditis or infection of a device implant and (2) documented antibiotic therapy. Main Outcomes and

Measures:

The primary outcomes of interest were device infection, device extraction, and all-cause mortality. Time-varying multivariable Cox proportional hazards regression models were used to evaluate the association between extraction and survival.

Results:

Among 1 065 549 patients (median age, 78.0 years [IQR, 72.0-84.0 years]; 50.9% male), mean (SD) follow-up was 4.6 (2.9) years after implantation. There were 11 304 patients (1.1%) with CIED infection (median age, 75.0 years [IQR, 67.0-82.0 years]); 60.1% were male, and 7724 (68.3%) had diabetes. A total of 2102 patients with CIED infection (18.6%) underwent extraction within 30 days of diagnosis. Infection occurred a mean (SD) of 3.7 (2.4) years after implantation, and 1-year survival was 68.3%. There was evidence of highly selective treatment, as most patients did not have extraction within 30 days of diagnosed infection (9202 [81.4%]), while 1511 (13.4%) had extraction within 6 days of diagnosis and 591 (5.2%) had extraction between days 7 and 30. Any extraction was associated with lower mortality compared with no extraction (adjusted hazard ratio [AHR], 0.82; 95% CI, 0.74-0.90; P < .001). Extraction within 6 days was associated with even lower risk of mortality (AHR, 0.69; 95% CI, 0.61-0.78; P < .001). Conclusions and Relevance In this study, a minority of patients with CIED infection underwent extraction. Extraction was associated with a lower risk of death compared with no extraction. The findings suggest a need to improve adherence to guideline-directed care among patients with CIED infection.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Desfibriladores Implantables / Endocarditis Límite: Aged / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: JAMA Cardiol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Desfibriladores Implantables / Endocarditis Límite: Aged / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: JAMA Cardiol Año: 2023 Tipo del documento: Article